Stand Up To Cancer (SU2C) recently announced a public service announcement (PSA) highlighting the research supported by donations to the organization.
SU2C launched a broadcast PSA this week to raise awareness and funds for cancer research.
The one-minute spot titled “It’s All in the Why” features five researchers and scientific leaders supported by SU2C’s funding. They discuss how the donations have allowed them to better care for their cancer patients with advancements in available treatment options.
The leaders that participated in the video include Brian Wolpin, MD, MPH and Kimberly Stegmaier, MD, both of the Dana-Farber Cancer Institute, Edith A. Perez, MD, chief medical officer at Bolt Biotherapeutics, Folasade P. May, MD, PhD, MPhil of the University of California, Los Angeles as well as John Carpten, PhD of the University of Southern California.
The PSA was originally aired in a longer format during the 2021 SU2C telecast but will now be supported by a broadcast push starting this month.
Additionally, the organization said that 30 and 15-second versions will run for 12 months via donated media across national and regional broadcast networks as well as out-of-home networks and digital platforms.
“This PSA draws attention to the fundamental connection to patients and the emotions and drive behind the work of our scientific leadership and funded researchers,” Stand Up to Cancer CEO Russell Chew said in a statement. “Continuing to fund this critical work and support those leading the charge against cancer is imperative to SU2C’s mission. We are so appreciative of the incredible work that all of our researchers are doing and are thankful to everyone featured in this PSA for sharing their voices to help call attention to the funding needed to push the newest and best cancer therapies forward.”
SU2C said that since its inception, it has raised $746 million for cancer research programs.
While many recognize SU2C’s work from their star-studded annual telecast, the organization continues to work throughout the year to raise awareness and funds for cancer research around the world.